Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Hereditary Angio Edema”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Not applicableStudy completedNCT01059526
What this trial is testing

Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 81
Very early researchEnded earlyNCT01694381
What this trial is testing

Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor

Who this might be right for
Acute Ischemic Stroke
TSI, LLC 8
Testing effectiveness (Phase 2)Study completedNCT04618211
What this trial is testing

Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+7 more
Pharvaris Netherlands B.V. 74
Large-scale testing (Phase 3)WithdrawnNCT01253382
What this trial is testing

Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire
Large-scale testing (Phase 3)Study completedNCT04654351
What this trial is testing

Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Takeda 2
Large-scale testing (Phase 3)Study completedNCT00292981
What this trial is testing

C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study)

Who this might be right for
Hereditary Angioedema
CSL Behring 57
Large-scale testing (Phase 3)Study completedNCT02741596
What this trial is testing

Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Who this might be right for
Hereditary Angioedema (HAE)
Shire 212
Testing effectiveness (Phase 2)Study completedNCT00261053
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Who this might be right for
Genetic Disorders
Pharming Technologies B.V. 14
Large-scale testing (Phase 3)Study completedNCT00456508
What this trial is testing

Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 147
Testing effectiveness (Phase 2)UnknownNCT04489160
What this trial is testing

Complement Inhibition: Attacking the Overshooting Inflammation @Fter Traumatic Brain Injury

Who this might be right for
Traumatic Brain InjuryTrauma, Head
Leiden University Medical Center 106
Large-scale testing (Phase 3)Study completedNCT00262301
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaAngioneurotic EdemaGenetic Disorders
Pharming Technologies B.V. 75
Testing effectiveness (Phase 2)Ended earlyNCT04414631
What this trial is testing

Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Who this might be right for
Coronavirus Infections
University Hospital, Basel, Switzerland 80
Large-scale testing (Phase 3)Looking for participantsNCT06361537
What this trial is testing

Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks

Who this might be right for
Acute Hereditary Angio Edema
Octapharma 124
Post-approval studies (Phase 4)Study completedNCT01467947
What this trial is testing

Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 46
Large-scale testing (Phase 3)Study completedNCT00457015
What this trial is testing

Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 96
Large-scale testing (Phase 3)Study completedNCT03888755
What this trial is testing

Icatibant for Acute Attacks of Hereditary Angioedema in Japanese Participants

Who this might be right for
Hereditary Angioedema (HAE)
Shire 8
Large-scale testing (Phase 3)Study completedNCT00997204
What this trial is testing

EASSI - Evaluation of the Safety of Self-Administration With Icatibant

Who this might be right for
Hereditary Angioedema
Shire 151
Testing effectiveness (Phase 2)Looking for participantsNCT07046806
What this trial is testing

Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients

Who this might be right for
Hereditary Angioedema (HAE)AngioedemaBradykinin-mediated Angioedema+1 more
Institute for Asthma and Allergy 10
Post-approval studies (Phase 4)WithdrawnNCT01151735
What this trial is testing

C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation

Who this might be right for
Hereditary Angioedema
Penn State University
Testing effectiveness (Phase 2)Study completedNCT01095510
What this trial is testing

CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12

Who this might be right for
Hereditary Angioedema (HAE)
Shire 9
Next Page